Lactobacillus Reuteri Versus Placebo in the Treatment and Prevention of Infantile Colic
Lactobacillus Reuteri Versus Placebo in the Treatment and Prevention of Infantile Colic: a Clinical and Microbiological, Double-blind, Prospective, Randomised, Controlled Study
Sponsor: Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Listed as NCT00893711, this NA trial focuses on Infantile Colic and remains ongoing. Sponsored by Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna, it has been updated 10 times since 2008, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Apr 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Apr 2021 — Apr 2023 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
-
May 2017 — May 2018 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE4
First recorded
Mar 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
For direct contact, visit the study record on ClinicalTrials.gov .